, 2020 Subject Management’ discussion and analysis for the fiscal year ended December 31, 2019 To President The Stock Exchange of Thailand Interpharma Public Company Limited ( “ the Company” ) would like
% Profit and Loss Statement Consolidated Financial Statement Comparison of the quaterly Separate Financial statement 30th June 2017 30th June 2017 Comparison of six-month period profit and loss ended June
August 15, 2017 Subject: MD&A for the financial statements of the 2nd quarter of fiscal year 2017 ended as of June 30, 2017 To: The President The Stock Exchange of Thailand Aapico Hitech Public Company
September 2017 and September 2016 Unit: Million Baht Profit and Loss Statement Consolidated Financial Statement Comparison of the quarterly Separate Financial statement 30 th Sep 2017 30 th Sep 2017 30 th Sep
) AAPICO HITECH PUBLIC COMPANY LIMITED Ref No: AH 01032020 March 3, 2020 Subject: Management Discussion & Analysis (MD&A) for the financial statements of fiscal year 2019 ended as of December 31, 2019 To
quarter of fiscal year 2019 ended as of June 30, 2019 To: The President The Stock Exchange of Thailand Aapico Hitech Public Company Limited (“the Company”) would like to clarify the consolidated financial
No: AH 03052021 May 17, 2021 Subject: Management Discussion & Analysis (MD&A) for the financial statements of the 1st quarter of fiscal year 2021 ended as of March 31, 2021 To: The President The Stock
No: AH 02112021 November 12, 2021 Subject: Management Discussion & Analysis (MD&A) for the financial statements of the 3rd quarter of fiscal year 2021 ended as of September 30, 2021 To: The President
No: AH 03052022 May 17, 2022 Subject: Management Discussion & Analysis (MD&A) for the Financial Statements of the 1st Quarter of Fiscal Year 2022 Ended as of March 31, 2022 To: The President The Stock
amount of Baht 13.4 million and Baht 23.9 million, respectively. Moreover, administrative expenses increase in this year due to recognize share based payment of Baht 61.2 million which are non-monetary